| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 262, Issue 1 72-R76, Copyright © 1992 by American Physiological Society
ARTICLES |
M. Lortie, D. Regoli, N. E. Rhaleb and G. E. Plante
Department of Physiology, University of Sherbrooke, Quebec, Canada.
Bradykinin (BK) is known to induce diuresis (UV), natriuresis (UNaV), and increased renal blood flow (RPF) with little or no change in glomerular filtration rate (GFR). In this study, BK is infused alone and concurrently with B1- or B2-kinin receptor antagonists into the left kidney of pentobarbital-anesthetized dogs. The intrarenal infusion of BK (bolus: 0.5 microgram/kg, followed by a sustaining dose: 0.05 micrograms.kg-1.min-1) affected left kidney function only. In the left kidney, UV increased from 0.42 +/- 0.21 to a maximum of 1.88 +/- 0.55 ml/min (P less than 0.01) and UNaV rose from 55 +/- 13 to 160 +/- 17 mueq/min (P less than 0.01), while RPF was enhanced from 86 +/- 11 to 125 +/- 24 ml/min (P less than 0.05), and GFR remained unchanged. When a B1-receptor antagonist ([Leu8]-des-Arg9-BK; 2.0 micrograms.kg-1.min-1) was infused concurrently with BK, the increase in urine flow was not different from BK alone. UNaV was transiently attenuated by 50% in this group (P less than 0.05). A B2-receptor antagonist (D-Arg0,[Hyp3,D-Phe7]-BK; 2.0 micrograms.kg-1.min-1) infused with BK significantly (P less than 0.05) and selectively inhibited by 50% the maximal diuresis provoked by BK alone. UNaV in this group was not different from that induced by BK alone. Finally, the concurrent infusion of either B1- or B2-antagonist completely inhibited the rise in RPF observed when BK was infused alone. We conclude that BK infused into the renal artery of dogs in vivo can alter UV and UNaV independently of global renal hemodynamic (RPF and GFR) changes.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  J. P. Schanstra, J. Duchene, F. Praddaude, P. Bruneval, I. Tack, J. Chevalier, J.-P. Girolami, and J.-L. Bascands Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1904 - H1908. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gabrielsen, P. Bie, N. H. Holstein-Rathlou, N. J. Christensen, J. Warberg, H. Dige-Petersen, E. Frandsen, S. Galatius, B. Pump, V. B. Sorensen, et al. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R459 - R467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. SCHANSTRA, M. E. MARIN-CASTAÑO, F. PRADDAUDE, I. TACK, J.-L. ADER, J.-P. GIROLAMI, J.-L. BASCANDS, and B. JEUNIER Bradykinin B1 Receptor-Mediated Changes in Renal Hemodynamics during Endotoxin-Induced Inflammation J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1208 - 1215. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. A. Ricupero, J. R. Romero, D. C. Rishikof, and R. H. Goldstein Des-Arg10-kallidin Engagement of the B1 Receptor Stimulates Type I Collagen Synthesis via Stabilization of Connective Tissue Growth Factor mRNA J. Biol. Chem., April 21, 2000; 275(17): 12475 - 12480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Praddaude, J. Marchetti, F. Alhenc-Gelas, and J.-L. Ader Dissimilar mechanisms of Ca2+ response to bradykinin in different types of juxtamedullary glomerular arterioles Am J Physiol Renal Physiol, November 1, 1999; 277(5): F697 - F705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Campbell, A. Kladis, T. A. Briscoe, and J. Zhuo Type 2 Bradykinin-Receptor Antagonism Does Not Modify Kinin or Angiotensin Peptide Levels Hypertension, May 1, 1999; 33(5): 1233 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bischoff, W. Rascher, and M. C. Michel Bradykinin may be involved in neuropeptide Y-induced diuresis, natriuresis, and calciuresis Am J Physiol Renal Physiol, October 1, 1998; 275(4): F502 - F509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Marceau, J. F. Hess, and D. R. Bachvarov The B1 Receptors for Kinins Pharmacol. Rev., September 1, 1998; 50(3): 357 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yu, O. A. Carretero, L. A. Juncos, and J. L. Garvin Biphasic Effect of Bradykinin on Rabbit Afferent Arterioles Hypertension, August 1, 1998; 32(2): 287 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Siragy, A. A. Jaffa, and H. S. Margolius Bradykinin B2 Receptor Modulates Renal Prostaglandin E2 and Nitric Oxide Hypertension, March 1, 1997; 29(3): 757 - 762. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Audet, F. Rioux, G. Drapeau, and F. Marceau Cardiovascular Effects of Sar-[D-Phe8]des-Arg9-Bradykinin, a Metabolically Protected Agonist of B1 Receptor for Kinins, in the Anesthetized Rabbit Pretreated with a Sublethal Dose of Bacterial Lipopolysaccharide J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 6 - 15. [Abstract] [Full Text]
|
|
|
|
|
|
J. B. O'Sullivan and S. B. Harrap Resetting Blood Pressure in Spontaneously Hypertensive Rats : The Role of Bradykinin Hypertension, February 1, 1995; 25(2): 162 - 165. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
